High‐frequency autonomic modulation: a new model for analysis of autonomic cardiac control
Background and Purpose Increase in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co‐activation which cannot be assessed directly using classic methods of heart rate variability analysis. The pr...
Saved in:
Published in | British journal of pharmacology Vol. 175; no. 15; pp. 3131 - 3143 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.08.2018
Wiley John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0007-1188 1476-5381 1476-5381 |
DOI | 10.1111/bph.14354 |
Cover
Abstract | Background and Purpose
Increase in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co‐activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed.
Experimental Approach
High‐frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non‐human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β‐blocker treatment and in subgroups of smoking and non‐smoking subjects.
Key Results
Three states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high‐frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co‐activated. S2 oscillations were proportionally increased by torsadogenic hERG‐blocking drugs, whereas smoking caused an increase in S3 oscillations.
Conclusions and Implications
The combined analysis of the magnitude of high‐frequency heart rate and high‐frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long‐term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity. |
---|---|
AbstractList | Increase in high-frequency beat-to-beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co-activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed.
High-frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non-human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β-blocker treatment and in subgroups of smoking and non-smoking subjects.
Three states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high-frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co-activated. S2 oscillations were proportionally increased by torsadogenic hERG-blocking drugs, whereas smoking caused an increase in S3 oscillations.
The combined analysis of the magnitude of high-frequency heart rate and high-frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long-term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity. Increase in high-frequency beat-to-beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co-activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed.BACKGROUND AND PURPOSEIncrease in high-frequency beat-to-beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co-activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed.High-frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non-human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β-blocker treatment and in subgroups of smoking and non-smoking subjects.EXPERIMENTAL APPROACHHigh-frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non-human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β-blocker treatment and in subgroups of smoking and non-smoking subjects.Three states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high-frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co-activated. S2 oscillations were proportionally increased by torsadogenic hERG-blocking drugs, whereas smoking caused an increase in S3 oscillations.KEY RESULTSThree states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high-frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co-activated. S2 oscillations were proportionally increased by torsadogenic hERG-blocking drugs, whereas smoking caused an increase in S3 oscillations.The combined analysis of the magnitude of high-frequency heart rate and high-frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long-term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity.CONCLUSIONS AND IMPLICATIONSThe combined analysis of the magnitude of high-frequency heart rate and high-frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long-term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity. Background and PurposeIncrease in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co‐activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed.Experimental ApproachHigh‐frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non‐human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β‐blocker treatment and in subgroups of smoking and non‐smoking subjects.Key ResultsThree states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high‐frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co‐activated. S2 oscillations were proportionally increased by torsadogenic hERG‐blocking drugs, whereas smoking caused an increase in S3 oscillations.Conclusions and ImplicationsThe combined analysis of the magnitude of high‐frequency heart rate and high‐frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long‐term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity. Background and Purpose Increase in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co‐activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed. Experimental Approach High‐frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non‐human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β‐blocker treatment and in subgroups of smoking and non‐smoking subjects. Key Results Three states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high‐frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co‐activated. S2 oscillations were proportionally increased by torsadogenic hERG‐blocking drugs, whereas smoking caused an increase in S3 oscillations. Conclusions and Implications The combined analysis of the magnitude of high‐frequency heart rate and high‐frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long‐term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity. |
Author | Champéroux, Pascal Fesler, Pierre Thireau, Jérôme Judé, Sebastien Le Guennec, Jean‐Yves Richard, Serge |
AuthorAffiliation | 1 Centre de Recherches Biologiques, CERB Baugy 18800 France 3 Laboratoire PHYMEDEXP,INSERM U1046, CNRS UMR 9214 Université de Montpellier, CHU Arnaud de Villeneuve Montpellier Cedex 05 34295 France 2 Department of Internal Medicine Hopital Lapeyronie Montpellier France |
AuthorAffiliation_xml | – name: 1 Centre de Recherches Biologiques, CERB Baugy 18800 France – name: 2 Department of Internal Medicine Hopital Lapeyronie Montpellier France – name: 3 Laboratoire PHYMEDEXP,INSERM U1046, CNRS UMR 9214 Université de Montpellier, CHU Arnaud de Villeneuve Montpellier Cedex 05 34295 France |
Author_xml | – sequence: 1 givenname: Pascal orcidid: 0000-0001-8175-1452 surname: Champéroux fullname: Champéroux, Pascal email: pascal.champeroux@cerb.fr organization: Centre de Recherches Biologiques, CERB – sequence: 2 givenname: Pierre surname: Fesler fullname: Fesler, Pierre organization: Université de Montpellier, CHU Arnaud de Villeneuve – sequence: 3 givenname: Sebastien surname: Judé fullname: Judé, Sebastien organization: Centre de Recherches Biologiques, CERB – sequence: 4 givenname: Serge surname: Richard fullname: Richard, Serge organization: Centre de Recherches Biologiques, CERB – sequence: 5 givenname: Jean‐Yves surname: Le Guennec fullname: Le Guennec, Jean‐Yves organization: Université de Montpellier, CHU Arnaud de Villeneuve – sequence: 6 givenname: Jérôme surname: Thireau fullname: Thireau, Jérôme organization: Université de Montpellier, CHU Arnaud de Villeneuve |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29723392$$D View this record in MEDLINE/PubMed https://hal.umontpellier.fr/hal-01785431$$DView record in HAL |
BookMark | eNp9kk1rFDEYx4NU7Lb14BeQAS96mDavM1kPQi3WFRb0UG9CyOSlm5JJ1mSmZW9-BD-jn6SZbq11QXN5IM_v_7wfgL0QgwHgBYLHqLyTbr06RpQw-gTMEG2bmhGO9sAMQtjWCHG-Dw5yvoKwOFv2DOzjeYsJmeMZ-LZwl6tfP37aZL6PJqhNJcchhtg7VfVRj14OLoa3layCuZl-jK9sTJUM0m-yy1W0jxRKJu1ksTEMKfoj8NRKn83ze3sIvp5_uDhb1MvPHz-dnS5rVeqhtVEWN1xqq6QmsEHU2NJExyhsO027ThNtuGqINbpjWCrLiDJzqzo8Zy3jhhyCd9u467HrjVamZJderJPrZdqIKJ342xPcSlzGa9FAgnhLSoA32wCrHdnidCmmP4hazihB16iwr--TpVhGlgfRu6yM9zKYOGaBIWG4oBwX9NUOehXHVCY3UU1pj3E6US8fV_-Q__eS_lSnUsw5GfuAICimAxDlAMTdART2ZIdVbrjbYWnc-f8pbpw3m3-HFu-_LLaKW8aNw7k |
CitedBy_id | crossref_primary_10_1007_s10072_021_05621_4 crossref_primary_10_1016_j_vascn_2024_107512 crossref_primary_10_3390_life12101659 crossref_primary_10_1038_s41598_022_12844_8 crossref_primary_10_1016_j_vascn_2023_107266 crossref_primary_10_1002_smi_3373 crossref_primary_10_1016_j_vascn_2023_107268 crossref_primary_10_2196_16654 crossref_primary_10_3390_biology11040603 crossref_primary_10_1111_jsr_13920 crossref_primary_10_1016_j_amcp_2024_09_005 crossref_primary_10_1016_j_isci_2021_103688 crossref_primary_10_25259_IJPP_553_2022 crossref_primary_10_1016_j_acvd_2024_05_097 crossref_primary_10_1111_bph_15905 |
Cites_doi | 10.1037/0033-295X.98.4.459 10.3389/fphys.2011.00086 10.1037/0735-7044.102.1.66 10.1111/bph.13093 10.1111/j.1476-5381.2010.00872.x 10.1126/science.6166045 10.1152/jappl.1993.75.5.2310 10.1016/j.ejpain.2010.11.011 10.1093/nar/gkx1121 10.1016/j.hrthm.2016.02.006 10.1016/j.jelectrocard.2012.08.001 10.1016/j.jacc.2007.03.045 10.1111/bph.13878 10.1161/01.CIR.93.5.1043 10.1097/00005344-199805000-00010 10.1111/bph.13391 10.1111/bph.14153 10.1161/01.CIR.100.1.27 10.1111/bph.12955 10.1088/0967-3334/15/2/006 10.1016/0002-9149(94)90400-6 10.2337/dc11-2120 10.1111/bph.13884 10.1161/STROKEAHA.110.607721 10.1161/01.CIR.0000047275.25795.17 10.1152/japplphysiol.00446.2006 10.1161/01.CIR.94.11.2850 10.1093/europace/euv015 10.1016/j.hrthm.2010.09.011 |
ContentType | Journal Article |
Copyright | 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. 2018 The British Pharmacological Society Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. – notice: 2018 The British Pharmacological Society – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7TK K9. NAPCQ 7X8 1XC VOOES 5PM |
DOI | 10.1111/bph.14354 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Calcium & Calcified Tissue Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | High‐frequency autonomic modulation |
EISSN | 1476-5381 |
EndPage | 3143 |
ExternalDocumentID | PMC6031873 oai_HAL_hal_01785431v1 29723392 10_1111_bph_14354 BPH14354 |
Genre | article Journal Article |
GroupedDBID | --- .3N .55 .GJ 05W 0R~ 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 52U 52V 53G 5GY 6J9 7RV 7X7 8-0 8-1 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 8UM AAESR AAEVG AAFWJ AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCUV ABDBF ABPVW ABQWH ABUWG ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFKRA AFRAH AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AHMBA AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB B0M BAFTC BAWUL BBNVY BENPR BFHJK BHBCM BHPHI BKEYQ BMXJE BPHCQ BRXPI BVXVI C45 CAG CCPQU COF CS3 DCZOG DIK DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS ECV EJD EMB EMK EMOBN ENC ESX EX3 F5P FUBAC FYUFA G-S GODZA GX1 H.X HCIFZ HGLYW HMCUK HYE HZ~ J5H KBYEO LATKE LEEKS LH4 LITHE LK8 LOXES LSO LUTES LW6 LYRES M1P M7P MEWTI MK0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NAPCQ NF~ O66 O9- OIG OK1 OVD P2P P2W PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q.N Q2X QB0 ROL RPM SJN SUPJJ SV3 TEORI TR2 TUS UKHRP UPT WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WVDHM WXSBR X7M XV2 Y6R YHG ZGI ZXP ZZTAW ~8M ~S- AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE ALIPV CITATION CGR CUY CVF ECM EIF NPM 7QP 7TK K9. 1OB 7X8 1XC VOOES 5PM |
ID | FETCH-LOGICAL-c4774-ecf268adfcad30614ef476b5407bd4bbd3de8c63fedb52acf53ce9fcb295758e3 |
IEDL.DBID | 24P |
ISSN | 0007-1188 1476-5381 |
IngestDate | Thu Aug 21 18:28:39 EDT 2025 Tue Jun 17 06:53:22 EDT 2025 Fri Sep 05 06:28:01 EDT 2025 Fri Jul 25 09:26:03 EDT 2025 Thu Apr 03 07:02:29 EDT 2025 Tue Jul 01 03:00:36 EDT 2025 Thu Apr 24 22:58:54 EDT 2025 Wed Aug 20 07:26:39 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 15 |
Keywords | heart rate variability power spectral analysis autonomic nervous system |
Language | English |
License | Attribution-NonCommercial 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4774-ecf268adfcad30614ef476b5407bd4bbd3de8c63fedb52acf53ce9fcb295758e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Equal contribution as senior authors. |
ORCID | 0000-0001-8175-1452 0000-0002-7831-6545 0000-0001-8791-4208 0000-0002-1641-5142 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbph.14354 |
PMID | 29723392 |
PQID | 2064075842 |
PQPubID | 42104 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6031873 hal_primary_oai_HAL_hal_01785431v1 proquest_miscellaneous_2035243182 proquest_journals_2064075842 pubmed_primary_29723392 crossref_primary_10_1111_bph_14354 crossref_citationtrail_10_1111_bph_14354 wiley_primary_10_1111_bph_14354_BPH14354 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2018 |
PublicationDateYYYYMMDD | 2018-08-01 |
PublicationDate_xml | – month: 08 year: 2018 text: August 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: Hoboken |
PublicationTitle | British journal of pharmacology |
PublicationTitleAlternate | Br J Pharmacol |
PublicationYear | 2018 |
Publisher | Blackwell Publishing Ltd Wiley John Wiley and Sons Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley – name: John Wiley and Sons Inc |
References | 2015; 17 2011; 2 1991; 98 1996; 94 1988; 102 1996; 93 2007; 50 2011; 15 1999; 100 2010; 160 2012; 35 2016; 13 2017a; 174 2018; 46 2018; 175 2015; 172 2003; 107 1981; 213 2017b; 174 1993; 75 2011; 42 1994; 15 2012; 45 1998; 31 2010; 7 2006; 101 1994; 74 2016; 173 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_12_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_10_1 e_1_2_10_11_1 e_1_2_10_30_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_28_1 e_1_2_10_25_1 e_1_2_10_26_1 |
References_xml | – volume: 98 start-page: 459 year: 1991 end-page: 487 article-title: Autonomic determinism: the modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint publication-title: Psychol Rev – volume: 93 start-page: 1043 year: 1996 end-page: 1065 article-title: Heart rate variability: standards of measurement, physiological interpretation, and clinical use publication-title: Circulation – volume: 174 start-page: S17 year: 2017b end-page: S129 article-title: The Concise Guide to PHARMACOLOGY 2017/18: G protein‐coupled receptors publication-title: Br J Pharmacol – volume: 75 start-page: 2310 year: 1993 end-page: 2317 article-title: Important influence of respiration on human R‐R interval power spectra is largely ignored publication-title: J Appl Physiol – volume: 46 start-page: D1091 year: 2018 end-page: D1106 article-title: The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY publication-title: Nucl Acids Res – volume: 102 start-page: 66 year: 1988 end-page: 76 article-title: Dissociation of associative and nonassociative concomitants of classical fear conditioning in the freely behaving rat publication-title: Behav Neurosci – volume: 2 start-page: 1 year: 2011 end-page: 13 article-title: Heart rate variability – a historical perspective publication-title: Front Physiol – volume: 7 start-page: 1797 year: 2010 end-page: 1805 article-title: Trigger‐specific risk factors and response to therapy in long QT syndrome type 2 publication-title: Heart Rhythm – volume: 15 start-page: 554 year: 2011 end-page: 560 article-title: Autonomic pain responses during sleep: a study of heart rate variability publication-title: Eur J Pain – volume: 100 start-page: 27 year: 1999 end-page: 32 article-title: Muscle metaboreflex contribution to sinus node regulation during static exercise: insights from spectral analysis of heart rate variability publication-title: Circulation – volume: 74 start-page: 340 year: 1994 end-page: 345 article-title: Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction publication-title: Am J Cardiol – volume: 45 start-page: 677 year: 2012 end-page: 683 article-title: The Telemetric and Holter ECG Warehouse (THEW): the first three years of development and research publication-title: J Electrocardiol – volume: 94 start-page: 2850 year: 1996 end-page: 2855 article-title: Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study publication-title: Circulation – volume: 101 start-page: 676 year: 2006 end-page: 682 article-title: Point: counterpoint: cardiovascular variability is/is not an index of autonomic control of circulation publication-title: J Appl Physiol – volume: 31 start-page: 714 year: 1998 end-page: 720 article-title: Autonomic effects of nicotine patch administration in habitual cigarette smokers: a double‐blind, placebo‐controlled study using spectral analysis of RR interval and systolic arterial pressure variabilities publication-title: J Cardiovasc Pharmacol – volume: 172 start-page: 3189 year: 2015 end-page: 3193 article-title: Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP publication-title: Br J Pharmacol – volume: 50 start-page: 335 year: 2007 end-page: 343 article-title: Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing‐induced congestive heart failure publication-title: J Am Coll Cardiol – volume: 13 start-page: 1309 year: 2016 end-page: 1316 article-title: Reference values for time‐ and frequency‐domain heart rate variability measures publication-title: Heart Rhythm – volume: 15 start-page: 163 year: 1994 end-page: 179 article-title: The accuracy of power‐spectrum analysis of heart‐rate variability from annotated RR list generated by Holter systems publication-title: Physiol Meas – volume: 172 start-page: 2878 year: 2015 end-page: 2891 article-title: Dofetilide induced QT interval short term variability and ventricular arrhythmias are dependent on high frequency autonomic oscillations publication-title: Br J Pharmacol – volume: 213 start-page: 220 year: 1981 end-page: 222 article-title: Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat‐to‐beat cardiovascular control publication-title: Science – volume: 107 start-page: 565 year: 2003 end-page: 570 article-title: Short‐term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients publication-title: Circulation – volume: 175 start-page: 987 year: 2018 end-page: 993 article-title: Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers publication-title: Brit J Pharmacol – volume: 160 start-page: 1577 year: 2010 end-page: 1579 article-title: NC3Rs reporting guidelines working group. Animal research: reporting in vivo experiments: the ARRIVE guidelines publication-title: Br J Pharmacol – volume: 173 start-page: 601 year: 2016 end-page: 612 article-title: The high frequency relationship: implications for torsadogenic hERG blockers publication-title: Br J Pharmacol – volume: 174 start-page: S160 year: 2017a end-page: S194 article-title: The Concise Guide to PHARMACOLOGY 2017/18: Voltage‐gated ion channels publication-title: Br J Pharmacol – volume: 17 start-page: 1341 year: 2015 end-page: 1353 article-title: Advances in heart rate variability signal analysis: joint position statement by the e‐Cardiology ESC Working Group and the European Heart Rhythm. Association co‐endorsed by the Asia Pacific Heart Rhythm Society publication-title: Europace – volume: 42 start-page: 1528 year: 2011 end-page: 1533 article-title: High NIHSS values predict impairment of cardiovascular autonomic control publication-title: Stroke – volume: 35 start-page: 1585 year: 2012 end-page: 1590 article-title: Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patients with type 1 diabetes publication-title: Diabetes Care – ident: e_1_2_10_5_1 doi: 10.1037/0033-295X.98.4.459 – ident: e_1_2_10_6_1 doi: 10.3389/fphys.2011.00086 – ident: e_1_2_10_16_1 doi: 10.1037/0735-7044.102.1.66 – ident: e_1_2_10_9_1 doi: 10.1111/bph.13093 – ident: e_1_2_10_17_1 doi: 10.1111/j.1476-5381.2010.00872.x – ident: e_1_2_10_2_1 doi: 10.1126/science.6166045 – ident: e_1_2_10_7_1 doi: 10.1152/jappl.1993.75.5.2310 – ident: e_1_2_10_10_1 doi: 10.1016/j.ejpain.2010.11.011 – ident: e_1_2_10_13_1 doi: 10.1093/nar/gkx1121 – ident: e_1_2_10_26_1 doi: 10.1016/j.hrthm.2016.02.006 – ident: e_1_2_10_11_1 doi: 10.1016/j.jelectrocard.2012.08.001 – ident: e_1_2_10_23_1 doi: 10.1016/j.jacc.2007.03.045 – ident: e_1_2_10_4_1 doi: 10.1111/bph.13878 – ident: e_1_2_10_29_1 doi: 10.1161/01.CIR.93.5.1043 – ident: e_1_2_10_21_1 doi: 10.1097/00005344-199805000-00010 – ident: e_1_2_10_8_1 doi: 10.1111/bph.13391 – ident: e_1_2_10_12_1 doi: 10.1111/bph.14153 – ident: e_1_2_10_15_1 doi: 10.1161/01.CIR.100.1.27 – ident: e_1_2_10_22_1 doi: 10.1111/bph.12955 – ident: e_1_2_10_25_1 doi: 10.1088/0967-3334/15/2/006 – ident: e_1_2_10_27_1 doi: 10.1016/0002-9149(94)90400-6 – ident: e_1_2_10_19_1 doi: 10.2337/dc11-2120 – ident: e_1_2_10_3_1 doi: 10.1111/bph.13884 – ident: e_1_2_10_14_1 doi: 10.1161/STROKEAHA.110.607721 – ident: e_1_2_10_20_1 doi: 10.1161/01.CIR.0000047275.25795.17 – ident: e_1_2_10_24_1 doi: 10.1152/japplphysiol.00446.2006 – ident: e_1_2_10_30_1 doi: 10.1161/01.CIR.94.11.2850 – ident: e_1_2_10_28_1 doi: 10.1093/europace/euv015 – ident: e_1_2_10_18_1 doi: 10.1016/j.hrthm.2010.09.011 |
SSID | ssj0014775 |
Score | 2.3549433 |
Snippet | Background and Purpose
Increase in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of... Increase in high-frequency beat-to-beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and... Background and PurposeIncrease in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of... |
SourceID | pubmedcentral hal proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3131 |
SubjectTerms | Adult Animals Autonomic Nervous System Dogs EKG Electrocardiography Female Heart - physiology Heart Rate Humans Life Sciences Macaca fascicularis Male Middle Aged Models, Cardiovascular Oscillations Parasympathetic nervous system Research Paper Research Papers Smoking Young Adult |
Title | High‐frequency autonomic modulation: a new model for analysis of autonomic cardiac control |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbph.14354 https://www.ncbi.nlm.nih.gov/pubmed/29723392 https://www.proquest.com/docview/2064075842 https://www.proquest.com/docview/2035243182 https://hal.umontpellier.fr/hal-01785431 https://pubmed.ncbi.nlm.nih.gov/PMC6031873 |
Volume | 175 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB615cIF8SZQkEGo4tCgreOsEziVR7U8tYdW6gEp8mOsRYJs1d1F2hs_gd_IL2HGzqa7Kkhc8vI4D48n_hLPfAPwFAc6FCgx1_XA5UoZmddodK5L600ZtEfk_5CfPg9HJ-r9aXm6BS9XsTCJH6L_4caWEd_XbODGztaM3J5NnvNgr7bhCofWct4Gqcb9FILSOqUvYBbEg6rqaIXYjaevujEYbU_YFfIyzrzsLrkOY-M4dHQdrnUAUhwmjd-ALWxvwt44MVAv98XxRUDVbF_sifEFN_XyFnxhv47fP3-F8-RCvRRmMU-hyeL71He5vF4IIwhui5gmRxCsFabjLhHTsFbDxe5F6-TvfhtOjt4evx7lXYKF3FHrqBxdkMPK-OCML_jTEIPSQ8ucfNYra33hsXLDIqC3pTQulIXDOjgra0J5FRZ3YKedtngPhKtL6QJSKesCB1Z7OwhIO15TBZXBs1VLN65jH-ckGN-a1VcIKaWJSsngSS96lig3_ipE6urLmSR7dPix4WP0jqk4wv_HQQa7K202nWnOGhnnLgl3yQwe98VkVDxTYlqcLliGcCmdoiKZu0n5_aUk52kjVJmB3ugWG_eyWdJ-nUTi7pjRWxfUFrED_fvpmlfjUdy4__-iD-AqgbkqOSfuws78fIEPCTDN7aNoGLR88-7DH3BGFqA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB615QCXijdpCxiEKg4N2jrOOkFcCqIKsK32sJV6QIr81CLRbNXuIu2tP6G_kV_CjJ1Nd1WQOOXhcR4eT_zFnvkG4I3rSZ857lJZ9kwqhOJp6ZRMZa6tyr20ztE85NFxvzoRX0_z0zX4sIiFifwQ3YQbWUb4XpOB04T0kpXr8_E7Gu3FOtwRiMvJoY-LYbeGIKSM-QuIBnG_KFpeIfLj6aqujEbrY_KFvA00b_tLLuPYMBAd3ofNFkGyg6jyB7DmmoewO4wU1PM9NrqJqLrcY7tseENOPX8E38mx4_fVtb-IPtRzpmbTGJvMzia2Teb1nimGeJuFPDkMcS1TLXkJm_ilGib0L9xGh_fHcHL4efSpStsMC6nB1hGpM573C2W9UTajf0PnhexrIuXTVmhtM-sK08-8szrnyvg8M670RvMSYV7hsiew0Uwa9wyYKXNuvMNSinN2PS2t7nmHB1ZiBZHA20VL16alH6csGD_rxW8IKqUOSkngdSd6Hjk3_iqE6urKiSW7OhjUdA4_MgWF-P_aT2Bnoc26tc3LmofFSwRePIFXXTFaFS2VqMZNZiSDwBQvUaDM06j87lacErUhrExArnSLlWdZLWl-jANzd0jpLTNsi9CB_v129cdhFXa2_l_0JdytRkeDevDl-Ns23ENkV0RPxR3YmF7M3HNET1P9IhjJH-84GRo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB61RUJcqvIOFDAIVRwatHWcdQKn8lgtUKocWqkHpMhPbaU2u2p3K-2Nn8Bv5JcwY2fTXRUkTnl4nIfHY3-JZ74BeO160meOu1SWPZMKoXhaOiVTmWurci-tc_Qf8vthf3gsvp7kJ2vwfhELE_khuh9uZBlhvCYDn1i_ZOR6MnpLk71Yh1u02EdWyUXVLSEIKWP6AmJB3CuKllaI3Hi6qiuT0fqIXCFv4syb7pLLMDbMQ4Mt2GwBJNuPGr8La665BztVZKCe77Kj64Cqy122w6prbur5ffhBfh2_f_7yF9GFes7UbBpDk9n52La5vN4xxRBus5AmhyGsZarlLmFjv1TDhO6F2-jv_gCOB5-PPg7TNsFCarB1ROqM5_1CWW-UzejT0Hkh-5o4-bQVWtvMusL0M--szrkyPs-MK73RvESUV7jsIWw048Y9BmbKnBvvsJTCnF1PS6t73uGBlVhBJPBm0dK1adnHKQnGWb34CkGl1EEpCbzqRCeRcuOvQqiurpxIsof7BzWdwzGmoAj_q70EthfarFvTvKx5WLvEDsMTeNkVo1HRSolq3HhGMohL8RIFyjyKyu9uxSlPG6LKBORKt1h5ltWS5nQUiLtDRm-ZYVuEDvTvt6s_VMOw8-T_RV_A7erToD74cvjtKdxBXFdEP8Vt2JhezNwzxE5T_TzYyB8hGhhD |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High%E2%80%90frequency+autonomic+modulation%3A+a+new+model+for+analysis+of+autonomic+cardiac+control&rft.jtitle=British+journal+of+pharmacology&rft.au=Champ%C3%A9roux%2C+Pascal&rft.au=Fesler%2C+Pierre&rft.au=Jud%C3%A9%2C+Sebastien&rft.au=Richard%2C+Serge&rft.date=2018-08-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=175&rft.issue=15&rft.spage=3131&rft.epage=3143&rft_id=info:doi/10.1111%2Fbph.14354&rft_id=info%3Apmid%2F29723392&rft.externalDocID=PMC6031873 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon |